APTOF.D

Aptose Biosciences Inc.

Healthcare · Biotechnology

$120.03 sample

-0.17 (-0.14%) 1D

Market cap

$733.0B

Price as of

2026-10-24

Latest filing

8-K · 2026-09-18

Alerts

8

Price$120.03 +2.22% 3M daily closessample

121.91115.57

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 19INSInsider sell: 10% owner
Oct 14INSInsider buy: Chief Executive Officer
Oct 08INSInsider sell: EVP, Operations
Oct 01INSInsider sell: Director
Sep 28INSInsider sell: General Counsel
Sep 18SECDEF 14A filed
Sep 14INSInsider sell: EVP, Operations
Sep 03INSInsider sell: Chief Financial Officer

Sign up to see the real APTOF.D record →

Company facts

SEC EDGAR registration

Name: Aptose Biosciences Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +53sample, -100 to +100
Reporting currency: USD

Who is positioning in APTOF.D

sample

Insiders: 19 insider transactions over 90 days, net selling, $229.7M
Congress: 2 members traded over 90 days
Institutions · 13F: 12 funds hold $13.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$26.6B +15.9% y/y

Q4 2024Q3 2026

Inventory$15.9B +13.4% y/y

Q4 2024Q3 2026

Accounts receivable$12.0B +6.0% y/y

Q4 2024Q3 2026

Total debt$33.8B +18.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $537.5B +8.6% 3M
Sample peer B: $76.0B +1.8% 3M
Sample peer C: $653.6B -8.3% 3M
Sample peer D: $677.0B -12.6% 3M
Sample peer E: $690.9B -6.9% 3M